1. Home
  2. ETNB vs HEPS Comparison

ETNB vs HEPS Comparison

Compare ETNB & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • HEPS
  • Stock Information
  • Founded
  • ETNB 2018
  • HEPS 2000
  • Country
  • ETNB United States
  • HEPS Turkey
  • Employees
  • ETNB N/A
  • HEPS N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • HEPS Catalog/Specialty Distribution
  • Sector
  • ETNB Health Care
  • HEPS Consumer Discretionary
  • Exchange
  • ETNB Nasdaq
  • HEPS Nasdaq
  • Market Cap
  • ETNB 1.0B
  • HEPS 1.1B
  • IPO Year
  • ETNB 2019
  • HEPS 2021
  • Fundamental
  • Price
  • ETNB $6.06
  • HEPS $2.89
  • Analyst Decision
  • ETNB Strong Buy
  • HEPS
  • Analyst Count
  • ETNB 10
  • HEPS 0
  • Target Price
  • ETNB $27.56
  • HEPS N/A
  • AVG Volume (30 Days)
  • ETNB 2.5M
  • HEPS 709.6K
  • Earning Date
  • ETNB 05-08-2025
  • HEPS 06-12-2025
  • Dividend Yield
  • ETNB N/A
  • HEPS N/A
  • EPS Growth
  • ETNB N/A
  • HEPS N/A
  • EPS
  • ETNB N/A
  • HEPS N/A
  • Revenue
  • ETNB N/A
  • HEPS $1,167,077,294.00
  • Revenue This Year
  • ETNB N/A
  • HEPS $43.21
  • Revenue Next Year
  • ETNB N/A
  • HEPS $37.58
  • P/E Ratio
  • ETNB N/A
  • HEPS N/A
  • Revenue Growth
  • ETNB N/A
  • HEPS 82.39
  • 52 Week Low
  • ETNB $4.16
  • HEPS $1.28
  • 52 Week High
  • ETNB $11.84
  • HEPS $4.05
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 42.57
  • HEPS 51.06
  • Support Level
  • ETNB $5.68
  • HEPS $2.52
  • Resistance Level
  • ETNB $6.13
  • HEPS $2.82
  • Average True Range (ATR)
  • ETNB 0.69
  • HEPS 0.14
  • MACD
  • ETNB 0.03
  • HEPS 0.03
  • Stochastic Oscillator
  • ETNB 51.62
  • HEPS 96.00

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About HEPS D-Market Electronic Services & Trading

D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues, and other revenues.

Share on Social Networks: